Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of tirbanibulin ointment versus vehicle for actinic keratosis on larger face or scalp treatment fields
NL-OMON59675Phase 3Completed
- Sponsor
- Almirall
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tirbanibulin, sponsored by Almirall. Started Mar 2024; status: completed.
02
Drugs
tirbanibulin
Beyond the preview
Go deeper on NL-OMON59675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59675.